Tumours increase their consumption of the amino acid tryptophan to evade immune control. But how does this work? A study shows that the main product of this consumption binds to a receptor involved in the immune system. See Article p.197
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Polypyrrole/carbon dot nanocomposite as an electrochemical biosensor for liquid biopsy analysis of tryptophan in the human serum of normal and breast cancer women
Analytical and Bioanalytical Chemistry Open Access 04 July 2023
-
USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer
Nature Communications Open Access 26 September 2022
-
Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models
Cancer & Metabolism Open Access 16 March 2021
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Opitz, C. A. et al. Nature 478, 197–203 (2011).
Schreiber, R. D., Old, L. J. & Smyth, M. J. Science 331, 1565–1570 (2011).
Munn, D. H. & Mellor, A. L. J. Clin. Invest. 117, 1147–1154 (2007).
Prendergast, G. C. Oncogene 27, 3889–3900 (2008).
Mellor, A. L. & Munn, D. H. Nature Rev. Immunol. 8, 74–80 (2008).
Fallarino, F., Gizzi, S., Mosci, P., Grohmann, U. & Puccetti, P. Curr. Drug Metab. 8, 209–216 (2007).
Katz, J. B., Muller, A. J. & Prendergast, G. C. Immunol. Rev. 222, 206–221 (2008).
Uyttenhove, C. et al. Nature Med. 9, 1269–1274 (2003).
Muller, A. J., Mandik-Nayak, L. & Prendergast, G. C. Immunotherapy 2, 293–297 (2010).
Muller, A. J. et al. Proc. Natl Acad. Sci. USA 105, 17073–17078 (2008).
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E. & Prendergast, G. C. Nature Med. 11, 312–319 (2005).
Balachandran, V. P. et al. Nature Med. 17, 1094–1100 (2011).
Mezrich, J. D. et al. J. Immunol. 185, 3190–3198 (2010).
Stevens, E. A., Mezrich, J. D. & Bradfield, C. A. Immunology 127, 299–311 (2009).
Prendergast, G. C., Metz, R. & Muller, A. J. Am. J. Pathol. 176, 2082–2087 (2010).
Vogel, C. F. A., Goth, S. R., Dong, B., Pessah, I. N. & Matsumura, F. Biochem. Biophys. Res. Commun. 375, 331–335 (2008).
Nguyen, N. T. et al. Proc. Natl Acad. Sci. USA 107, 19961–19966 (2010).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prendergast, G. Why tumours eat tryptophan. Nature 478, 192–194 (2011). https://doi.org/10.1038/478192a
Published:
Issue Date:
DOI: https://doi.org/10.1038/478192a
This article is cited by
-
Polymeric nanoparticles tryptophan-graft-p(HEMA): a study on synthesis, characterization, and toxicity
Polymer Bulletin (2023)
-
Polypyrrole/carbon dot nanocomposite as an electrochemical biosensor for liquid biopsy analysis of tryptophan in the human serum of normal and breast cancer women
Analytical and Bioanalytical Chemistry (2023)
-
USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer
Nature Communications (2022)
-
Kynurenines in polycystic kidney disease
Journal of Nephrology (2022)
-
The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies
Medical Oncology (2022)
